DOI: 10.1055/s-00000125

Senologie - Zeitschrift für Mammadiagnostik und -therapie


Marty M, Cognetti F, Maraninchi D et al.
Randomized phase II trial of the efficacy andsafety of trastuzumab combined with docetaxel in patients with humanepidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatment: the M77001 study group.

J ClinOncol 2005;
23: 4265-4274

Download Bibliographical Data

Search in: